PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 18, Pages 2322-2332
Publisher
Springer Nature
Online
2015-08-10
DOI
10.1038/onc.2015.292
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin
- (2015) Sari Toropainen et al. NUCLEIC ACIDS RESEARCH
- PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells
- (2015) Martin Puhr et al. Oncotarget
- SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner
- (2014) Päivi Sutinen et al. NUCLEIC ACIDS RESEARCH
- PIAS1 Regulates Breast Tumorigenesis through Selective Epigenetic Gene Silencing
- (2014) Bin Liu et al. PLoS One
- Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancer
- (2014) Rosa Nadal et al. PROSTATE
- Akt SUMOylation Regulates Cell Proliferation and Tumorigenesis
- (2013) R. Li et al. CANCER RESEARCH
- Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer
- (2013) R.J. van Soest et al. EUROPEAN JOURNAL OF CANCER
- Anterior gradient 2and3- two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells
- (2013) Huajie Bu et al. FEBS Journal
- Posttranslational Modification of the Androgen Receptor in Prostate Cancer
- (2013) Travis Van der Steen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of the SUMO modification system is required for the accumulation of RAD51 at sites of DNA damage
- (2013) H. Shima et al. JOURNAL OF CELL SCIENCE
- PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21
- (2012) Julia Hoefer et al. AMERICAN JOURNAL OF PATHOLOGY
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
- (2012) R. Hu et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Dynamic SUMOylation Is Linked to the Activity Cycles of Androgen Receptor in the Cell Nucleus
- (2012) M. Rytinki et al. MOLECULAR AND CELLULAR BIOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer
- (2011) A Marije Hoogland et al. MODERN PATHOLOGY
- Cyclin-Dependent Kinase 16/PCTAIRE Kinase 1 Is Activated by Cyclin Y and Is Essential for Spermatogenesis
- (2011) P. Mikolcevic et al. MOLECULAR AND CELLULAR BIOLOGY
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
- (2009) J. J. Driscoll et al. BLOOD
- Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways
- (2009) M. Puhr et al. CANCER RESEARCH
- PIAS proteins: pleiotropic interactors associated with SUMO
- (2009) Miia M. Rytinki et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Androgen Modulation of Coregulator Expression in Prostate Cancer Cells
- (2009) Hannelore V. Heemers et al. MOLECULAR ENDOCRINOLOGY
- Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks
- (2009) Yaron Galanty et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started